Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3
Journal of Immunology Research · 2024
DOI: 10.1155/2024/9512251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Yizhi Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics The 2nd Affiliated Hospital Nanjing Medical University, 262 North Zhongshan Road, Nanjing 210003, Jiangsu, China. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Fibrosis, Macrophage Activation, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing Medical University.
Abstract (Originalsprache)
Macrophage alternative activation is involved in kidney fibrosis. Previous researches have documented that the transcriptional regulators Yes‐associated protein (Yap)/transcriptional coactivator with PDZ‐binding motif (Taz) are linked to organ fibrosis. However, limited knowledge exists regarding the function and mechanisms of their downstream molecules in regulating macrophage activation and kidney fibrosis. In this paper, we observed that the Hippo pathway was suppressed in macrophages derived from fibrotic kidneys in mice. Knockout of Taz or Tead1 in macrophages inhibited the alternative activation of macrophages and reduced kidney fibrosis. Additionally, by using bone marrow–derived macrophages (BMDMs), we investigated that knockout of Taz or Tead1 in macrophages impeded both cell proliferation and migration. Moreover, deletion of Tead1 reduces p‐Smad3 and Smad3 abundance in macrophages. And chromatin immunoprecipitation (ChIP) assays showed that Tead1 could directly bind to the promoter region of Smad3. Collectively, these results indicate that Tead1 knockout in macrophages could reduce TGF β 1‐induced phosphorylation Smad3 via transcriptional downregulation of Smad3, thus suppressing macrophage alternative activation and IRI‐induced kidney fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics The 2nd Affiliated Hospital Nanjing Medical University, 262 North Zhongshan Road, Nanjing 210003, Jiangsu, China.
- Center for kidney diseases The 2nd Affiliated Hospital Nanjing Medical University, 262 North Zhongshan Road, Nanjing 210003, Jiangsu, China.
- School of Stomatology Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou 221000, Jiangsu, China.
ORCID-Profile: Yizhi Ren, Chunsun Dai
Förderung
- National Natural Science Foundation of China
- Nanjing Medical University
Zitieren
APA
Ren, Y., Zhou, L., Li, X., Zhu, X., Zhang, Z., Sun, X., Xue, X., & Dai, C. (2024). Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3. Journal of Immunology Research. https://doi.org/10.1155/2024/9512251
Vancouver
Ren Y, Zhou L, Li X, Zhu X, Zhang Z, Sun X, et al. Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3. Journal of Immunology Research. 2024. doi:10.1155/2024/9512251
BibTeX
@article{Ren2024,
author = {Ren, Yizhi and Zhou, Lu and Li, Xinyuan and Zhu, Xingwen and Zhang, Zhiheng and Sun, Xiaoli and Xue, Xian and Dai, Chunsun},
title = {Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3},
journal = {Journal of Immunology Research},
year = {2024},
doi = {10.1155/2024/9512251}
}
EUVIMED